Representative batches? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-08-05 14:45 (5006 d 05:45 ago) – Posting: # 5726
Views: 15,460

Dear Dan!

❝ But can you argue with the assessor without statistics?


Statistics – A subject which most statisticians find difficult
but in which nearly all physicians are expert.
Stephen Senn

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.
Stephen Senn; Statistical Issues in Drug Development. Wiley, p386, 2004


❝ As other sponsors we selected T & R batches which matched closely. Comparative dissolution profiles showed similarity and the assay content differed less than 5%.

❝ From the quality point of view we see no difference between the batches.


Yes, everybody did/does it that way (see also the last paragraph in ElMaestro’s post). Of course that's not representative, but 'best'.

❝ The logic consequence would be that for the release of any batch you produce for the market you have to perform a BE study as quality control.


Yes, but would be applicable to the innovator as well. I would remind the assessor that this idea was already abandoned 15+ years ago and on the consequences.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,661 registered users;
100 visitors (1 registered, 99 guests [including 8 identified bots]).
Forum time: 20:30 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5